Nationwide settlement for $7 billion approved over Roundup cancer claims

Nationwide settlement for $7 billion approved over Roundup cancer claims

A $7 billion settlement was issued on Friday over agrochemical giant Bayer’s popular weedkiller Roundup, which plaintiffs claimed caused non-Hodgkin lymphoma.The ruling comes out of Missouri, where Judge Timothy Boyer ordered Bayer to pay the settlement to thousands of Americans over a 20-year period. Recommended Stories Bayer, which denies any wrongdoing, has already changed the formula of Roundup sold to residential customers. The Germany-based company, which is popular among American farmers, said the agreement provides some future financial relief to mounting lawsuits on the issue. The settlement comes months after the U.S. Supreme Court ruled that plaintiffs cannot use state courts to sue over missing cancer warnings when the U.S. Environmental Protection Agency does not require them.SENATE PASSES HISTORIC BILL TO CUT ENVIRONMENTAL RED TAPE ON ENERGY PROJECTSNon-Hodgkin lymphoma is a type of cancer of the lymphatic system, which drains excess fluid from body tissues and supports the immune system. Farmers and agricultural workers face higher exposure levels and have shown elevated NHL rates in several studies by the Occupational Cancer Research Centre.EPA stated that the active ingredient in Roundup, glyphosate, is not cancer-causing when used as directed.

Original Source

Read the full article at Washingtonexaminer →

KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.